Shares of ExamWorks (NYSE: EXAM) jumped to a new all-time high Wednesday, after the provider of independent medical examinations late Tuesday reported a narrowed Q4 net loss that was smaller than expected while revenue topped Street estimates and the company forecast Q1 and 2014 revenue above analysts’ expectations.
EXAM was up 17% at $35.76 recently, after hitting the fresh record at $36.85.
The company posted a Q4 net loss of $1.6 million, or $0.04 per share, compared with a prior-year net loss of $2.7 million, or $0.08 per share. Analysts polled by Capital IQ were expecting a loss of $0.06 per share.
Revenue climbed 14% to $158.8 million, boosted by organic growth of 12% and acquisition growth of 1.9%. Analysts’ mean estimate was $152 million.
EXAM said it expects Q4 revenue of $165 million and $170 million, reflecting an expected growth rate of 11% to 14%. The average of three analyst estimates was $157.6 million.
It expects 2014 revenue will increase between 13.5% and 15.5% from 2013’s $616 million, implying a range of $699.2 million to $711.5 million. Analysts were looking for $646.2 million.
JAKKS Pacific, Inc (NASDAQ: JAKK) is higher in pre-market trading after the company reported financial results for Q4 topped analysts’ expectations, and said it expects Q1 to be below Street forecasts and issued mixed FY14 guidance.
Shares are up 15.08% at $6.79, with a 52-week range of $4.45 – $12.32.
The multi-line, multi-brand toy company reported Q4 a loss of $0.73 per share, which includes $0.23 per share in restructuring charges, compared with the prior-year period’s $5.45 per share, which also includes $4.18 per share charge related to the impairment of deferred tax assets. Excluding the charge, Q4 adjusted loss per share would be $0.50. This compares with the Capital IQ consensus estimate of $0.82 loss per share.
Revenue was $137.7 million, up from $133.5 million in the same quarter last year. Analysts were expecting $128.72 million. The company expects Q1 loss per share of $0.77 – $0.81, wider than the consensus of $0.74 loss per share. Revenues are expected to be $72 million – $75 million, below the Street view of $79.95 million.
For fiscal 2014, the company sees EPS of 0.30- $0.40, better than the consensus of $0.24 EPS; revenues are projected to be $633 million – $640 million, below the Street estimate of $642.82 million.